Gene · 7376
Papers1,865
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,865
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shared genetics and causal relationships between major depressive disorder and COVID-19 related traits: a large-scale genome-wide cross-trait meta-analysis. | Front Psychiatry | 2023 | 37426090 | PubTator, text mining | PubMed |
| Activation of invasion by oncogenic reprogramming of cholesterol metabolism via increased NPC1 expression and macropinocytosis. | Oncogene | 2023 | 37420029 | PubTator, text mining | PubMed |
| Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies. | Front Immunol | 2023 | 37388737 | PubTator, text mining | PubMed |
| Real-Time Search-Assisted Multiplexed Quantitative Proteomics Reveals System-Wide Translational Regulation of Non-Canonical Short Open Reading Frames. | Biomolecules | 2023 | 37371559 | PubTator, text mining | PubMed |
| Neuron-astrocyte omnidirectional signaling in neurological health and disease. | Front Mol Neurosci | 2023 | 37363320 | PubTator, text mining | PubMed |
| Full-length nuclear receptor allosteric regulation. | J Lipid Res | 2023 | 37356665 | PubTator, text mining | PubMed |
| Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort. | Br J Cancer | 2023 | 37355720 | PubTator, text mining | PubMed |
| Liver X receptors induce antiproliferative effects in basal-like breast cancer. | Mol Oncol | 2023 | 37341140 | PubTator, text mining | PubMed |
| Signaling mechanisms in renal compensatory hypertrophy revealed by multi-omics. | Nat Commun | 2023 | 37328470 | PubTator, text mining | PubMed |
| Liver X receptors and estrogen receptor β, two players in a rare subtype of NSCLC. | Int J Biol Sci | 2023 | 37324952 | PubTator, text mining | PubMed |
| Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo. | Front Pharmacol | 2023 | 37324449 | PubTator, text mining | PubMed |
| A novel dammarane triterpenoid alleviates atherosclerosis by activating the LXRα pathway. | Chin Med | 2023 | 37322486 | PubTator, text mining | PubMed |
| Association between abnormal lipid metabolism and tumor. | Front Endocrinol (Lausanne) | 2023 | 37305043 | PubTator, text mining | PubMed |
| Glioblastoma Metabolism: Insights and Therapeutic Strategies. | Int J Mol Sci | 2023 | 37298093 | PubTator, text mining | PubMed |
| A Multi-Omics Overview of Colorectal Cancer to Address Mechanisms of Disease, Metastasis, Patient Disparities and Outcomes. | Cancers (Basel) | 2023 | 37296894 | PubTator, text mining | PubMed |
| Lanosterol synthase loss of function decreases the malignant phenotypes of HepG2 cells by deactivating the Src/MAPK signaling pathway. | Oncol Lett | 2023 | 37274468 | PubTator, text mining | PubMed |
| Establishing plausibility of cardiovascular adverse effects of immunotherapies using Mendelian randomisation. | Front Cardiovasc Med | 2023 | 37273876 | PubTator, text mining | PubMed |
| RNA sequencing and bioinformatics analysis of differentially expressed genes in the peripheral serum of ankylosing spondylitis patients. | J Orthop Surg Res | 2023 | 37254181 | PubTator, text mining | PubMed |
| Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad? | Endocr Rev | 2023 | 37253115 | PubTator, text mining | PubMed |
| β-Sitosterol as a Promising Anticancer Agent for Chemoprevention and Chemotherapy: Mechanisms of Action and Future Prospects. | Adv Nutr | 2023 | 37247842 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7376/papers?page=8